UFP INDUSTRIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data UFP INDUSTRIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,297	4,006	4,489	4,416	5,154	8,636	9,627	7,218	6,652	6,320
Cost of revenue	2,766	3,398	3,896	3,730	4,354	7,229	7,837	5,799	5,426	5,260
Gross profit	475	543	593	686	800	1,407	1,789	1,419	1,227	1,060
Selling, general and administrative	310	362	392	439	445	682	832	767	735	691
Operating expenses								772	735	696
Operating income	164	181	207	245	346	738	950	647	492	364
Interest expense	4.58	6.22	8.89	8.7	9.31	13.8	13.9	12.8	12.7	10.9
Interest income	0.54	0.73	1.37	1.95	2.39
Other non-operating income	-3.77	-5.46	-9.41	-4.23	-4.84	-11.2	-15.4	24.7	47.9	28.3
Pre-tax income	161	176	198	241	341	726	935	671	540	392
Income tax	55.2	52	45.4	58.3	87.1	174	230	157	121	96.2
Net income to minority interests	4.32	4.53	3.81	2.75	7.1	16.7	12.3	0.15	4.17	1.2
Net income	101	120	149	180	247	536	693	514	415	295
EBITDA	205	230	262	305	410	822	1,044	757	617	502
EPS, basic	1.66	1.95	2.41	2.91	4.00	8.61	11.05	8.21	6.78	5.00
EPS, diluted	1.65	1.94	2.40	2.91	4.00	8.59	10.97	8.07	6.77	5.00
Shares, basic (weighted)	60.1	60.3	60.4	60.1	59.9	60.2	60.2	59.6	58.8	56.7
Shares, diluted (weighted)	60.2	60.4	60.4	60.1	59.9	60.4	60.7	60.6	58.9	56.8
Dividend per share			0.18	0.40	0.50	0.65	0.95	1.10	1.32	1.40

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	34.1	28.3	27.3	168	437	287	559	1,118	1,172	914
Short-term investments		11.3	14.8	18.5	24.3	36.5	36	34.7	31.1	34.4
Receivables	282	328	343	364	471	738	618	549	501	476
Inventory	397	460	556	487	567	963	973	728	721	722
Other current assets	20.7	28.1	38.5	41.7	33.8	39.8	42.5	38.5	50	66.5
Total current assets	756	863	995	1,093	1,538	2,073	2,262	2,502	2,503	2,269
Property, plant and equipment	298	329	355	387	417	589	689	777	891	993
Lease right-of-use assets				80.2	77.2	96.7	108	104	115	116
Goodwill	199	213	224	230	252	315	337	336	340	344
Intangible assets	26.7	34.9	41.5	48.3	72.3	109	144	175	152	134
Other non-current assets	8.62	7.37	8.66	24.9	20.3	31.9	101	87.4	98.4	102
Total assets	1,292	1,465	1,648	1,889	2,405	3,245	3,672	4,018	4,151	4,023
Accounts payable	125	140	137	142	212	319	207	203	225	206
Accrued liabilities	92.4	97.6	104	142	166	289	296	232	193	188
Deferred revenue		4.44	3.25	6.62	11.5	10.7	10.2	9.49	6.48	3.96
Short-term debt	2.63	1.33	0.15	2.82	0.1	42.7	2.94	42.9	4.13	0.9
Total current liabilities	272	303	310	354	464	776	612	568	512	494
Long-term debt	109	145	202	161	312	278	275	234	230	229
Lease liabilities				64.9	61.5	76.6	85.4	84.9	95.1	99.1
Other non-current liabilities	29.9	28.7	30.9	29.1	59.6	37.5	44.7	35.9	32.3	28.8
Total liabilities	432	491	559	632	922	1,229	1,068	968	901	934
Total debt	112	146	203	164	312	320	278	276	234	230
Paid-in capital	145	162	179	192	218	244	294	355	403	445
Retained earnings	649	736	840	995	1,183	1,678	2,217	2,582	2,775	2,559
Other comprehensive income	-5.63	0.14	-5.94	-4.89	-1.79	-5.41	-9.08	1.11	-15.3	1.56
Shareholders' equity	849	959	1,073	1,244	1,460	1,979	2,564	3,000	3,224	3,062
Minority interests	11.3	14.5	15.3	14	22.8	38	32.8	30.4	20.6	21.9
Total equity	860	974	1,089	1,258	1,483	2,017	2,597	3,030	3,245	3,084
Total liabilities and equity	1,292	1,465	1,648	1,889	2,405	3,245	3,672	4,018	4,151	4,023
Shares outstanding	61	61.2	60.9	61.4	61.2	61.9	61.6	61.6	60.7	56.6

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	105	124	152	182	254	552	705	514	419	296
Depreciation and amortization	40.8	48.5	54.9	60.5	64	84.2	94.1	111	125	138
Stock-based compensation	2.2	3.6	3.6	4	4	11.2	28.2	34.9	38.2	37.8
Deferred income tax	0.29	-7.27	0.88	7.1	2.74	7.36	-13.2	-5.86	-15	49.2
Change in receivables	-5.12	-30.8	-8.51	-16.9	-87.6	-85.4	131	81.7	47.1	27.5
Change in inventory	-3.25	-49.3	-84.3	73.1	-76	-260	0.72	251	6.36	7.29
Change in payables	11.3	21.2	-5.21	-24.1	62.4	78.1	-138	-3.58	22.4	-20.2
Cash from operations	173	137	117	349	336	512	832	960	643	546
Capital expenditures	-53.8	-71.1	-95.9	-84.9	-89.2	-151	-174	-180	-232	-269
Acquisitions	-80.1	-60.6	-54
Purchases of investments	-5.67	-13.5	-13.3	-13.4	-28.1	-23.8	-19.9	-29.8	-55.4	-38.8
Cash from investing	-228	-138	-121	-142	-155	-611	-354	-240	-271	-273
Debt issued		8.53	75		150
Debt repaid		-13.3	-5.54	-3.14			-38.7	-0.03	-40
Stock issued	0.54	0.66	1.03	1.09	1.4	2.12	2.77	2.75	2.81	2.47
Share buybacks	0	-13	-24.6		-29.2		-95.8	-82.1	-141	-433
Dividends paid	-3.28	-19.6	-22.1	-24.5	-30.7	-40.2	-58.9	-68.2	-80.8	-82.4
Cash from financing	3.21	-5.25	4.39	-67.3	85.2	-45	-210	-163	-307	-530
Exchange rate effect	-1.93	0.65	-0.46	0.48	0.96	-1.67
Net change in cash	-53.9	-5.67	-0.62	140	268	-145	268	563	57.3	-255
Free cash flow	119	65.5	20.8	264	247	361	657	780	410	276
Interest paid	4.55	6.02	8.86	8.76	7.2	14.1	14	12.7	12.8	10.9
Income taxes paid	57.3	56.7	51.6	50.2	78	167	275	158	135	67.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $79.49 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	16.1%	Gross profit / revenue.
Operating margin	5.1%	Operating income / revenue.
EBITDA margin	7.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.4%	Pre-tax income / revenue.
Net margin	4.0%	Net income / revenue.
FCF margin	4.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.9%	Cash from operations / revenue.
Effective tax rate	26.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.1%	Net income / average total assets.
Return on invested capital (ROIC)	8.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	11.0%	Selling, general and administrative expense / revenue.
Capex / revenue	3.6%	Capital expenditures / revenue.
D&A / revenue	2.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-13.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-13.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-16.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	5.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-26.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-27.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	1.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-18.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-21.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	4.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-28.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-24.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	3.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-26.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-23.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	4.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-15.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-13.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	10.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-32.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-25.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	2.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	6.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	13.8%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	22.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-5.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	6.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	16.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-3.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.98x	Current assets / current liabilities.
Quick ratio	2.47x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.15x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.08x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	5.7%	Total debt / total assets.
Liabilities / assets	25.5%	Total liabilities / total assets.
Net debt	-$409.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.89x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	31.1x	Operating income / interest expense.
Working capital	$1.66B	Current assets - current liabilities.
Goodwill and intangibles / assets	11.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.56B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.52x	Revenue / average total assets.
Fixed asset turnover	5.77x	Revenue / average property, plant and equipment.
Inventory turnover	6.99x	Cost of revenue / average inventory.
Days inventory	52 days	365 x average inventory / cost of revenue.
Receivables turnover	8.53x	Revenue / average receivables.
Days sales outstanding	43 days	365 x average receivables / revenue.
Days payables	20 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	75 days	Days inventory + days sales outstanding - days payables.
FCF conversion	107.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	45.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$4.36	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$115.66	Revenue / diluted weighted shares.
FCF per share	$4.95	Free cash flow / diluted weighted shares.
Operating cash flow per share	$9.15	Cash from operations / diluted weighted shares.
Book value per share	$55.07	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$46.47	Tangible book value / shares outstanding.
Cash per share	$11.67	(Cash + short-term investments) / shares outstanding.
Payout ratio	32.4%	Dividends paid / net income, when net income is positive.
Dividends / FCF	30.2%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	120.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$4.38B	Share price x shares outstanding.
Enterprise value	$3.98B	Market cap + total debt - cash - short-term investments.
P/E	17.6x	Market cap / net income. Only when net income is positive.
P/S	0.70x	Market cap / revenue.
P/B	1.44x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.71x	Market cap / tangible book value, when positive.
P/FCF	16.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.89x	Market cap / cash from operations, when positive.
EV/Sales	0.64x	Enterprise value / revenue.
EV/EBIT	12.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.63x	Enterprise value / EBITDA, when both are positive.
EV/FCF	14.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.1%	Free cash flow / market cap.
Earnings yield	5.7%	Net income / market cap (the inverse of P/E).
Dividend yield	1.8%	Dividends paid over the period / market cap.
Shareholder yield	9.2%	(Dividends paid + share buybacks) / market cap.

What was UFP INDUSTRIES INC's revenue in fiscal 2025?

UFP INDUSTRIES INC reported revenue of $6.32B for fiscal 2025, 5% lower than the year before.

Was UFP INDUSTRIES INC profitable in fiscal 2025?

Yes. Net income was $294.8M, a net margin of 4.7%.

How much free cash flow did UFP INDUSTRIES INC generate in fiscal 2025?

Cash from operations of $545.7M minus capital expenditures of $269.4M left free cash flow of $276.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to UFP INDUSTRIES INC